StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD opened at $0.35 on Friday. The stock has a market cap of $586,488.00, a PE ratio of -0.09 […]
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report report published on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD opened at $0.39 on Friday. The stock has a market capitalization of $648,480.00, a P/E ratio […]
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of NASDAQ GLMD opened at $0.39 on Friday. The firm has a market cap of $648,480.00, a PE ratio of […]
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report issued on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of NASDAQ GLMD opened at $0.31 on Friday. Galmed Pharmaceuticals has a 12-month low of $0.26 and a 12-month high […]
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report released on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Up 7.7 % NASDAQ GLMD opened at $0.32 on Friday. The company has a market capitalization of $532,392.00, a price-to-earnings ratio of -0.08 […]